Integrating CAR-T cell therapy into the management of DLBCL: what we are learning.

Massimo MartinoFilippo Antonio CanaleGaetana PortoChiara VerduciGiovanna UtanoGiorgia PolicastroJessyca GermanòCaterina AlatiLudovica SantoroLucrezia ImbalzanoMartina Pitea

Published in: Expert opinion on biological therapy (2023)

This review aims to describe the current landscape of CAR-T cells in DLBCL, outline their outcomes and toxicities, and explain the outstanding questions that remain to be addressed.

Keyphrases

cell therapy
diffuse large b cell lymphoma
stem cells
mesenchymal stem cells
single cell
type diabetes
metabolic syndrome
bone marrow
adipose tissue
weight loss
insulin resistance